Actively Recruiting
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Led by Boehringer Ingelheim · Updated on 2026-03-17
80
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this trial is to assess bioequivalence of two formulations of survodutide (formulation A and formulation B6) after multiple-dose treatment in male and female trial participants living with overweight or obesity.
CONDITIONS
Official Title
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy male or female participants confirmed by medical history, physical exam, vital signs, ECG, and lab tests
- Age between 18 and 65 years inclusive
- Body Mass Index (BMI) between 27.0 and 39.9 kg/m² inclusive
- Signed informed consent according to regulations
- For women of childbearing potential: using highly effective contraception from 28 days before first dose until 28 days after trial completion, or surgically sterilised, or postmenopausal with no menses for 1 year without other cause
You will not qualify if you...
- Any clinically relevant abnormal findings in medical exam, vital signs, or ECG
- Repeated blood pressure measurements outside 90-150 mmHg systolic or 50-100 mmHg diastolic
- Pulse rate outside 50-100 bpm
- Clinically relevant abnormal lab values
- Any clinically relevant concomitant disease
- Gastrointestinal, liver, kidney, lung, heart, metabolic, immune, or hormonal disorders
- Central nervous system diseases including seizures, stroke, or psychiatric disorders
- History of orthostatic hypotension, fainting, or blackouts
- Recent acute or chronic infections within 4 weeks prior to screening
- Further exclusion criteria apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Quotient Sciences
Nottingham, United Kingdom, NG11 6JS
Actively Recruiting
Research Team
B
Boehringer Ingelheim
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here